CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024
Operating activities:
Net (loss) income	$ (30,514)	$ (41,008)
Less: net loss from discontinued operations, net of tax	0	11,196
Net loss from continuing operations	(30,514)	(29,812)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	12,227	14,549
Unrealized gain foreign currency	(81)	(1,923)
Stock-based compensation	4,363	4,092
Change in fair value of warrants	(1,187)	582
Amortization of debt discount and deferred issuance costs	6,867	1,499
Deferred income tax	121	(462)
Provision for doubtful accounts	(254)	(355)
Gain on disposition of assets	0	(1,250)
Non-cash lease expense	13,511	13,528
Changes in operating assets and liabilities:
Accounts receivable	15,999	33,284
Prepaid expenses and other current assets and prepaid expenses and other assets	(10,655)	4,628
Accounts payable	4,118	(30,639)
Accrued compensation	(350)	1,140
Accrued expenses, other current liabilities, and other liabilities	(9,580)	4,181
Lease liabilities	(16,808)	(16,469)
Deferred revenue	5,204	(548)
Cash used in operating activities from continuing operations	(7,019)	(3,975)
Net cash used in operating activities from discontinued operations	0	(12,149)
Net cash used in operating activities	(7,019)	(16,124)
Investing activities:
Capital expenditures	(1,678)	(500)
Capitalization of internal-use software	(9,636)	(9,294)
Business combinations, net of cash acquired	(233)	0
Proceeds from sale of asset	300	350
Cash used in investing activities from continuing operations	(11,247)	(9,444)
Cash provided by investing activities from discontinued operations	0	108,575
Cash (used in) provided by investing activities	(11,247)	99,131
Financing activities:
Borrowings from Term Loan	43,975	0
Borrowings from film financing arrangements	5,342	0
Proceeds from co-financing arrangements for feature films	2,662	0
Payment on Convertible Notes	(30,000)	(31,233)
Payment of consent solicitation fees	(2,089)	0
Payment on Revolving Credit Facility	0	(33,837)
Payment of early termination fee for Revolving Credit Facility	0	(500)
Payment of Term Loan's debt issuance costs	(754)	0
Repurchase of common stock	(3,332)	0
Proceeds from exercise of stock options	16	1
Payment for shares withheld for employee taxes	(191)	(291)
Proceeds from the issuance of common stock in connection with the at-the-market offering, net of issuance costs	(175)	660
Distributions to noncontrolling interests	(1,923)	0
Cash provided by (used in) financing activities	13,531	(65,200)
Effect of currency translation on cash and cash equivalents	379	279
Net (decrease) increase in cash and cash equivalents	(4,356)	18,086
Cash and cash equivalents at beginning of period	38,648	35,637
Cash and cash equivalents at end of period	$ 34,292	$ 53,723